Tammara Vijay 4

Accession 0001192482-21-000388

CIK 0001372299other

View on SEC.gov Company Profile

Filed

May 2, 8:00 PM ET

Accepted

May 3, 8:53 PM ET

Size

28.8 KB

Accession

0001192482-21-000388

Insider Transaction Report

Form 4

Period: 2021-04-29

Ocugen, Inc.OCGN

Tammara Vijay

Vice President

Transactions

Sale
Common Stock
2021-04-29$10.97/sh−9,000$98,730→ 0 total
Exercise/Conversion
Common Stock
2021-04-29$2.94/sh+3,000$8,820→ 3,000 total
Sale
Common Stock
2021-04-29$10.99/sh−3,000$32,970→ 0 total
Exercise/Conversion
Common Stock
2021-04-29$0.51/sh+12,880$6,569→ 12,880 total
Exercise/Conversion
Comm Stock
2021-04-29$0.46/sh+9,000$4,140→ 9,000 total
Exercise/Conversion
Options (Right to Buy)
2021-04-29−5,111→ 44,889 total
Exercise: $0.57Exp: 2030-08-14→ Common Stock (5,111 underlying)
Sale
Common Stock
2021-04-29$10.96/sh−12,880$141,165→ 0 total
Exercise/Conversion
Common Stock
2021-04-29$0.57/sh+5,111$2,913→ 5,111 total
Sale
Common Stock
2021-04-29$10.96/sh−5,111$56,017→ 0 total
Exercise/Conversion
Common Stock
2021-05-03$0.46/sh+4,317$1,986→ 4,317 total
Sale
Common Stock
2021-05-03$16.00/sh−4,317$69,072→ 0 total
Exercise/Conversion
Options (Right to Buy)
2021-04-29−9,000→ 9,217 total
Exercise: $0.46Exp: 2024-09-18→ Common Stock (9,000 underlying)
Exercise/Conversion
Options (Right to Buy)
2021-04-29−3,000→ 4,191 total
Exercise: $2.94Exp: 2026-04-26→ Common Stock (3,000 underlying)
Exercise/Conversion
Options (Right to Buy)
2021-04-29−12,880→ 64,761 total
Exercise: $0.51Exp: 2030-01-02→ Common Stock (12,880 underlying)
Exercise/Conversion
Options (Right to Buy)
2021-05-03−4,317→ 4,900 total
Exercise: $0.46Exp: 2024-09-18→ Common Stock (4,317 underlying)

Footnotes (7)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
[F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.86 to $11.06. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) - (4) to this Form 4.
[F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.86 to $11.07.
[F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.86 to $11.07.
[F5]All of the options became exerciable immediately upon grant.
[F6]34,507 shares under the option are exercisable. The option, initially representing a right to purchase a total of 77,641 shares, vests and becomes exercisable over three years commencing on January 2, 2021, subject to continued service with the Company on the applicable vesting dates.
[F7]111,111 shares under the option are exercisable. The option, initially representing a right to purchase a total of 50,000 shares, vests and becomes exercisable over three years commencing on August 14, 2020, subject to continued service with the Company on the applicable vesting dates.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

Ocugen, Inc.

CIK 0001372299

→

Entity typeother

Related Parties

filerCIK 0001791822

Filing Metadata

Form type: 4
Filed: May 2, 8:00 PM ET
Accepted: May 3, 8:53 PM ET
Size: 28.8 KB

View on SEC.gov